FDA Drug recall D-0881-2018
0.45% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc
- FDA Drug
- Class II
- terminated
- Published 2018-06-27
On 2018-06-27 the FDA classified a Class II recall of 0.45% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc by Icu Medical, citing lack of assurance of sterility: Bags have potential to leak.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0881-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-05-31 |
| Published | 2018-06-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Icu Medical |
| Distribution | US |
Product
0.45% Sodium Chloride Injection, USP, 100 mL bag, Rx Only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-7730-37
Reason
Lack of assurance of sterility: Bags have potential to leak.
Identifiers
| code_info | Lot #: 85-023-JT, Exp 7/1/2019 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0881-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.